scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Naveed Ahmed Khan | Q61081517 |
Ruqaiyyah Siddiqui | Q86651636 | ||
Ayaz Anwar | Q89523436 | ||
Abdulkader Masri | Q90633115 | ||
P2860 | cites work | Mechanistic Basis of Antimicrobial Actions of Silver Nanoparticles | Q28079834 |
ZnO nanoparticles enhanced antibacterial activity of ciprofloxacin against Staphylococcus aureus and Escherichia coli | Q28275835 | ||
Introduction to metallic nanoparticles | Q28384965 | ||
Design and Synthesis of Self-Degradable Antibacterial Polymers by Simultaneous Chain- and Step-Growth Radical Copolymerization | Q28468162 | ||
Emerging and Neglected Infectious Diseases: Insights, Advances, and Challenges | Q30235317 | ||
Facial control of nanoparticle binding to cytochrome C. | Q33274544 | ||
De novo design of antimicrobial polymers, foldamers, and small molecules: from discovery to practical applications | Q33598664 | ||
Nanoparticle-stabilized liposomes for pH-responsive gastric drug delivery | Q33763705 | ||
Stimuli-responsive liposome fusion mediated by gold nanoparticles. | Q33814671 | ||
Nanomedicine in the Management of Microbial Infection - Overview and Perspectives | Q34245494 | ||
Active silver nanoparticles for wound healing | Q34330664 | ||
Nanoparticle approaches against bacterial infections | Q34339159 | ||
Nanotechnology on duty in medical applications | Q34396935 | ||
Cell-specific targeting of nanoparticles by multivalent attachment of small molecules | Q34462201 | ||
Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery | Q35809872 | ||
Bulk Surfaces Coated with Triangular Silver Nanoplates: Antibacterial Action Based on Silver Release and Photo-Thermal Effect | Q36321321 | ||
Auranofin-loaded nanoparticles as a new therapeutic tool to fight streptococcal infections | Q36500235 | ||
Multidrug-Resistant Bacteria in the Community: Trends and Lessons Learned | Q37648626 | ||
The antimicrobial activity of nanoparticles: present situation and prospects for the future | Q37652887 | ||
Development of nanoparticles for antimicrobial drug delivery | Q37656410 | ||
Drug delivery systems for potential treatment of intracellular bacterial infections | Q37663202 | ||
Nanomaterial standards for efficacy and toxicity assessment | Q37668451 | ||
Aminoglycoside therapy in infectious diseases | Q38112810 | ||
Mechanisms of nanotoxicity: generation of reactive oxygen species | Q38199789 | ||
Gold nanoparticles: various methods of synthesis and antibacterial applications | Q38217570 | ||
Shape-dependent antibacterial effects of non-cytotoxic gold nanoparticles | Q38730503 | ||
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date | Q38853466 | ||
Esculentin-1a-Derived Peptides Promote Clearance of Pseudomonas aeruginosa Internalized in Bronchial Cells of Cystic Fibrosis Patients and Lung Cell Migration: Biochemical Properties and a Plausible Mode of Action | Q39349164 | ||
Multivalent gold nanoparticle-peptide conjugates for targeting intracellular bacterial infections | Q40049719 | ||
Formulation of carbapenems loaded gold nanoparticles to combat multi-antibiotic bacterial resistance: In vitro antibacterial study | Q40250246 | ||
Identification and characterization of antibacterial compound(s) of cockroaches (Periplaneta americana). | Q40506281 | ||
Bacterial Hyaluronidase Self-Triggered Prodrug Release for Chemo-Photothermal Synergistic Treatment of Bacterial Infection | Q40521036 | ||
Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics | Q41869149 | ||
Strong Near-Infrared Absorbing and Biocompatible CuS Nanoparticles for Rapid and Efficient Photothermal Ablation of Gram-Positive and -Negative Bacteria. | Q41991353 | ||
Small molecule-capped gold nanoparticles as potent antibacterial agents that target Gram-negative bacteria | Q42938419 | ||
Selective binding of mannose-encapsulated gold nanoparticles to type 1 pili in Escherichia coli. | Q43944501 | ||
Surface-modified superparamagnetic nanoparticles for drug delivery: preparation, characterization, and cytotoxicity studies | Q45070455 | ||
Size selectivity in antibiofilm activity of 3-(diphenylphosphino)propanoic acid coated gold nanomaterials against Gram-positive Staphylococcus aureus and Streptococcus mutans | Q46572072 | ||
Antibacterial and hemolytic activities of pyridinium polymers as a function of the spatial relationship between the positive charge and the pendant alkyl tail | Q46818353 | ||
Deposition of CTAB-terminated nanorods on bacteria to form highly conducting hybrid systems | Q46848910 | ||
Surface Functionalization of Iron Oxide Nanoparticles with Gallic Acid as Potential Antioxidant and Antimicrobial Agents | Q47163288 | ||
Nanoantibiotics: Future nanotechnologies to combat antibiotic resistance | Q47177239 | ||
Loading of polymyxin B onto anionic mesoporous silica nanoparticles retains antibacterial activity and enhances biocompatibility. | Q47218574 | ||
Synthesis of 4-(dimethylamino)pyridine propylthioacetate coated gold nanoparticles and their antibacterial and photophysical activity. | Q47697037 | ||
Magnetic iron oxide nanoparticles as drug carriers: clinical relevance | Q47708026 | ||
Brain-Eating Amoebae: Silver Nanoparticle Conjugation Enhanced Efficacy of Anti-Amoebic Drugs against Naegleria fowleri | Q47932685 | ||
Charged Metallopolymer-Grafted Silica Nanoparticles for Antimicrobial Applications | Q48134551 | ||
Gut bacteria of cockroaches are a potential source of antibacterial compound(s). | Q49861586 | ||
Garcinia indica mediated biogenic synthesis of silver nanoparticles with antibacterial and antioxidant activities | Q50056364 | ||
Synthesis and characterization of biogenic metal nanoparticles and its cytotoxicity and anti-neoplasticity through the induction of oxidative stress, mitochondrial dysfunction and apoptosis | Q50064330 | ||
Differential Contribution of Constituent Metal Ions to the Cytotoxic Effects of Fast-Dissolving Metal-Oxide Nanoparticles | Q50109145 | ||
Antibacterial Activity of DNA-Stabilized Silver Nanoclusters Tuned by Oligonucleotide Sequence | Q50202986 | ||
Antibacterial Synergy of Silver Nanoparticles with Gentamicin and Chloramphenicol against Enterococcus faecalis. | Q50333346 | ||
Mechanisms of Bacterial Resistance to Antimicrobial Agents. | Q52718658 | ||
Magnetic graphene oxide inlaid with silver nanoparticles as antibacterial and drug delivery composite. | Q53440100 | ||
Evaluating the antimicrobial, apoptotic, and cancer cell gene delivery properties of protein-capped gold nanoparticles synthesized from the edible mycorrhizal fungus Tricholoma crassum. | Q53681430 | ||
Synthesis and Biomedical Applications of Multifunctional Nanoparticles | Q57168175 | ||
Nanoscale Structure–Activity Relationships, Mode of Action, and Biocompatibility of Gold Nanoparticle Antibiotics | Q57442848 | ||
Microscopic localization of PEG-liposomes in a rat model of focal infection | Q57779723 | ||
Combatting antibiotic-resistant bacteria using nanomaterials | Q59312956 | ||
Cationic Silver Nanoclusters as Potent Antimicrobials against Multidrug-Resistant Bacteria | Q60913978 | ||
Synthesis of non-toxic, biocompatible, and colloidal stable silver nanoparticle using egg-white protein as capping and reducing agents for sustainable antibacterial application | Q61660033 | ||
Antimicrobial activities of green synthesized gums-stabilized nanoparticles loaded with flavonoids | Q64093008 | ||
Recent insights on nanomedicine for augmented infection control | Q64093635 | ||
Lipase-sensitive polymeric triple-layered nanogel for "on-demand" drug delivery | Q83391527 | ||
Silver Nanoparticle Conjugation-Enhanced Antibacterial Efficacy of Clinically Approved Drugs Cephradine and Vildagliptin | Q93178334 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 4 | |
P921 | main subject | nanomedicine | Q261659 |
P577 | publication date | 2019-12-11 | |
P1433 | published in | Antibiotics (Basel, Switzerland) | Q27725829 |
P1476 | title | The Use of Nanomedicine for Targeted Therapy against Bacterial Infections | |
P478 | volume | 8 |
Search more.